M Sprintz, E Tasciotti, M Allegri, A Grattoni… - European Journal of …, 2011 - Elsevier
Pain, be it acute, chronic, or any permutation thereof, is a universal problem affecting greater than 1.5 billion people worldwide, with over 116million in the US, and over 164 million …
Objective The objective of this article is to critically review both preclinical and clinical studies that focus on the use of nanotechnology for both acute and chronic pain …
V Andreu, M Arruebo - Journal of Controlled Release, 2018 - Elsevier
Pain is a widespread and growing health problem worldwide that exerts a considerable social and economic impact on both patients and healthcare systems and, therefore, on …
Transdermal administration of analgesic medications offers several benefits over alternative routes of administration, including a decreased systemic drug load with fewer side effects …
Pain is one of the most common medical conditions and affects more Americans than diabetes, heart disease, and cancer combined. Current pain treatments mainly rely on …
Y Xu, X Dong, H Xu, P Jiao, LX Zhao, G Su - Pharmaceutics, 2023 - mdpi.com
The use of nanomaterials in drug delivery systems for pain treatment is becoming increasingly common. This review aims to summarize how nanomaterial-based drug …
Acute or chronic pain is a major source of impairment in quality of life and affects a substantial part of the population. To date, pain is alleviated by a limited range of treatments …
MR Moradkhani, A Karimi… - … cells, nanomedicine, and …, 2018 - Taylor & Francis
Prolonged delivery of analgesic drugs at target sites remains a critical issue for efficient pain management. The use of nano-carriers has been reported to facilitate applicable delivery of …
BS Chhikara - Journal of Materials NanoScience, 2017 - pubs.thesciencein.org
Applications of Nanoparticles and nanopharmulations in drug development and drug delivery have been an extensive field of research to find out the alternative better …